Skip to main content
logo
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.26
+0.27 (1.17%)
Apr 24, 2026, 10:36 AM EDT - Market open

Immunome Revenue

In the year 2025, Immunome had annual revenue of $6.94M, down -23.23%.

Revenue (ttm)
$6.94M
Revenue Growth
-23.23%
P/S Ratio
379.12
Revenue / Employee
$39,215
Employees
177
Market Cap
2.63B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.94M-2.10M-23.23%
Dec 31, 20249.04M-4.98M-35.50%
Dec 31, 202314.02M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ADMA Biologics510.17M
Zai Lab460.16M
Tarsus Pharmaceuticals451.36M
IDEAYA Biosciences218.71M
Soleno Therapeutics190.41M
Nektar Therapeutics55.23M
Celldex Therapeutics1.55M
Revenue Rankings

IMNM News

More News